Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Index level readings help identify whether markets are overbought or consolidating. This quick intro shows what high vs low levels mean for trend and risk.
27,260 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
As geopolitical tensions flare and oil costs surge, recession odds jump higher. Moody's Analytics now grids a near-50...
BuzzFeed wins a brief reprieve on a $5 million debt due May 18, after a prior going-concern warning. The move spooks ...
When celebrities step into a gas station, the moment goes beyond entertainment. This article explores how a high-prof...
NVIDIA stock investors just received a wave of favorable headlines from Wall Street. Strong AI demand, rising price t...
As the AI arms race accelerates, Microsoft leans on Copilot to reverse signals of lost momentum. Early traction and p...
Squid Crypto raised $6 million with Ripple backing, only to see $3 million drained in a 24-hour window as a periphera...
Mercer (MERC) 2026 earnings outlook explained. This analysis breaks down Q1 results, key metrics, and what to expect ...
As retirees seek steady cash flow, a single Realty Income position could approach $33,000 annually, but concentration...
Public subsidies have funded stadiums for decades, but seating is shrinking and prices are rising. A closer look reve...
Anthropic aims to go public this fall, but mounting regulatory pressures risk undercutting its valuation. Investors a...
Policy-driven biofuel mandates could lift gasoline prices, signaling a hidden price spike coming for drivers. The EPA...